Anaptysbio (ANAB) Receivables - Other (2016 - 2019)

Anaptysbio (ANAB) has 4 years of Receivables - Other data on file, last reported at $175000.0 in Q1 2019.

• Quarterly Receivables - Other fell 89.13% year-over-year to $175000.0 in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $175000.0 (down 89.13% YoY) and the FY2018 annual result came in at $174000.0, down 89.13% from the prior year.
• Receivables - Other grew to $175000.0 in Q1 2019, from $174000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $5.6 million in Q2 2017 to a low of $174000.0 in Q4 2018.
• A 4-year average of $2.0 million and a median of $1.6 million in 2017 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2017 — Receivables - Other slumped 61.12% — and 2018, when it plunged 96.45%.
• Tracing ANAB's Receivables - Other over 4 years: stood at $4.1 million in 2016, then slumped by 61.12% to $1.6 million in 2017, then tumbled by 89.13% to $174000.0 in 2018, then grew by 0.57% to $175000.0 in 2019.
• The last three Receivables - Other figures came in at $175000.0 (Q1 2019), $174000.0 (Q4 2018), and $200000.0 (Q3 2018), per Business Quant data.